| Cannabidiol protects an in vitro model of the blood–brain barrier from oxygen‐glucose deprivation via PPARγ and 5‐HT1A receptors WH Hind, TJ England, SE O'Sullivan British journal of pharmacology 173 (5), 815-825, 2016 | 168 | 2016 |
| Is the cardiovascular system a therapeutic target for cannabidiol? CP Stanley, WH Hind, SE O'Sullivan British journal of clinical pharmacology 75 (2), 313-322, 2013 | 140 | 2013 |
| Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation CP Stanley, WH Hind, C Tufarelli, SE O'Sullivan Cardiovascular research 107 (4), 568-578, 2015 | 104 | 2015 |
| Endocannabinoids modulate human blood–brain barrier permeability in vitro WH Hind, C Tufarelli, M Neophytou, SI Anderson, TJ England, ... British journal of pharmacology 172 (12), 3015-3027, 2015 | 101 | 2015 |
| Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke M Ceprián, L Jiménez-Sánchez, C Vargas, L Barata, W Hind, ... Neuropharmacology 116, 151-159, 2017 | 98 | 2017 |
| Cannabinoids in experimental stroke: a systematic review and meta-analysis TJ England, WH Hind, NA Rasid, SE O'sullivan Journal of Cerebral Blood Flow & Metabolism 35 (3), 348-358, 2015 | 97 | 2015 |
| Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage L Barata, L Arruza, MJ Rodríguez, E Aleo, E Vierge, E Criado, E Sobrino, ... Neuropharmacology 146, 1-11, 2019 | 52 | 2019 |
| MyD88-dependent and-independent signalling via TLR3 and TLR4 are differentially modulated by Δ9-tetrahydrocannabinol and cannabidiol in human macrophages JM Fitzpatrick, E Minogue, L Curham, H Tyrrell, P Gavigan, W Hind, ... Journal of neuroimmunology 343, 577217, 2020 | 43 | 2020 |
| Cannabidiol administration prevents hypoxia-ischemia-induced hypomyelination in newborn rats M Ceprián, C Vargas, L García-Toscano, F Penna, L Jiménez-Sánchez, ... Frontiers in Pharmacology 10, 1131, 2019 | 34 | 2019 |
| The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries CP Stanley, WH Hind, C Tufarelli, SE O’Sullivan Pharmacological research 113, 356-363, 2016 | 34 | 2016 |
| Cannabidiol reduces lung injury induced by hypoxic–ischemic brain damage in newborn piglets L Arruza, MR Pazos, N Mohammed, N Escribano, H Lafuente, M Santos, ... Pediatric research 82 (1), 79-86, 2017 | 26 | 2017 |
| Phytocannabinoid‐dependent mTORC1 regulation is dependent upon inositol polyphosphate multikinase activity JL Damstra‐Oddy, EC Warren, CJ Perry, Y Desfougères, JMK Fitzpatrick, ... British Journal of Pharmacology 178 (5), 1149-1163, 2021 | 20 | 2021 |
| Use of cannabidiol in the treatment of tuberous sclerosis complex B Whalley, H William, G Royston, M Bazelot, IDS SERRA, C Williams, ... US Patent App. 16/624,106, 2020 | 20 | 2020 |
| Botanically-Derived Δ9-Tetrahydrocannabinol and Cannabidiol, and Their 1:1 Combination, Modulate Toll-like Receptor 3 and 4 Signalling in Immune Cells from … JM Fitzpatrick, B Hackett, L Costelloe, W Hind, EJ Downer Molecules 27 (6), 1763, 2022 | 5 | 2022 |
| Effects of Cannabidiol, Hypothermia, and Their Combination in Newborn Rats with Hypoxic-Ischemic Encephalopathy FJ Alvarez, AA Alvarez, JJ Rodríguez, H Lafuente, MJ Canduela, W Hind, ... eneuro 10 (5), 2023 | 2 | 2023 |
| Cannabidiol reduces intraventricular hemorrhage brain damage, preserving myelination and preventing blood brain barrier dysfunction in immature rats A Del Pozo, M de Hoz-Rivera, A Romero, M Villa, M Martínez, L Silva, ... Neurotherapeutics 21 (2), e00326, 2024 | 1 | 2024 |
| Cannabidiol Reduces Inflammatory Lung Damage After Meconium Aspiration in Newborn Piglets L Arruza, L Barata, E Vierge, MJ Rodríguez, A Del Pozo, W Hind, ... Frontiers in Pediatrics 10, 862035, 2022 | 1 | 2022 |
| An Investigation Into the Effects of Cannabinoids on the Permeability of an in Vitro Model of the Blood-brain Barrier, in Normal Physiology and Following Ischaemic Stroke WH Hind University of Nottingham, 2014 | 1 | 2014 |
| Use of cannabinoids in the treatment of a neurodegenerative disease or disorder B Whalley, H William, G Royston, J Fernandez-Ruiz, E De Lago, ... US Patent 11,944,600, 2024 | | 2024 |
| Use of cannabidiol in the treatment of tuberous sclerosis complex B Whalley, H William, G Royston, M Bazelot, IDS SERRA, C Williams, ... US Patent App. 18/161,603, 2023 | | 2023 |
